Are peptides legal? It depends on which peptide and how it's sold. FDA-approved peptide drugs, such as semaglutide and tirzepatide, are legal with a prescription. "Research use only" (RUO) peptides aren't approved drugs, and FDA treats them as illegal unapproved new drugs when a seller's marketing shows they're meant for people. Most peptides aren't controlled substances, which is one way they differ from anabolic steroids.
Notice: This is a plain-language summary of public regulatory sources, not legal or medical advice. Research peptides are not FDA-approved and not for human or animal consumption. Rules change often, so check with a lawyer or your state board for your own situation. Last reviewed September 26, 2026.
What counts as a "peptide" under federal law
A peptide is a short chain of amino acids linked by peptide bonds, typically 2 to 50, according to the National Human Genome Research Institute. FDA draws a regulatory line at 40: under its 2020 rule, a chain of more than 40 amino acids is a "protein" and regulated as a biological product. Shorter peptides are generally regulated as drugs.
In practice, legal status comes down to three questions:
- Is the product an approved drug being prescribed and dispensed normally?
- Is it being compounded by a licensed pharmacy under federal compounding rules?
- Or is it sold online as a research chemical, outside both of those systems?
Prescription peptide drugs: legal with a prescription
Several of the best-known peptide medicines are FDA-approved:
- Semaglutide: approved as Ozempic for type 2 diabetes on December 5, 2017, and as Wegovy for chronic weight management on June 4, 2021.
- Tirzepatide: approved as Mounjaro for type 2 diabetes in May 2022, and as Zepbound for chronic weight management on November 8, 2023.
These are legal when prescribed by a licensed clinician and dispensed by a pharmacy. The same molecule sold as a "research" vial online is not the approved product. See semaglutide vs tirzepatide for what the trials found.
Research-use-only peptides: not approved, and the label isn't a shield
Online vendors sell peptides such as BPC-157, TB-500 and GLP-1-class compounds labeled "for research use only" and "not for human consumption." That label doesn't make a product legal to sell for human use.
Under the Federal Food, Drug, and Cosmetic Act, a product's status depends on its intended use, judged from the full context of how it's sold. FDA's March 31, 2026 letter to Gram Peptides states:
"Despite statements on your product labeling marketing your products for 'Research Use Only,' evidence obtained from your website establishes that your products are intended to be drugs for human use."
The 2026 letters cite health claims, dosing information, injection instructions, dose calculators and bundled injection supplies as evidence of human use (details). FDA's page on unapproved GLP-1 drugs says it has warned companies that "illegally sold unapproved drugs containing semaglutide, tirzepatide, retatrutide, survodutide or mazdutide that are falsely labeled 'for research purposes' or 'not for human consumption.'"
Enforcement has gone beyond letters. In July 2026, the owner of Paradigm Peptides was sentenced to 70 months for introducing unapproved new drugs into interstate commerce with intent to defraud or mislead. Our 2025-2026 timeline tracks other vendors that were warned or shut down.
FDA's actions we reviewed target sellers, not people who buy. We didn't find a federal source that addresses buyers directly, so we don't make claims either way about personal purchase or possession.
Are peptides controlled substances?
Generally, no. DEA's list of controlled substances (dated August 27, 2026) doesn't include BPC-157, TB-500, ipamorelin, CJC-1295, semaglutide, tirzepatide or retatrutide. That's a key difference from anabolic steroids, which Congress placed in Schedule III (DEA). More in are peptides steroids?
One exception worth knowing: human growth hormone isn't a scheduled drug, but federal law makes it a crime to knowingly distribute it for uses in humans that FDA hasn't authorized, punishable by up to 5 years in prison (21 U.S.C. 333(e)).
Compounding: what changed in 2025-2026
Licensed pharmacies can compound some drugs from bulk ingredients under sections 503A and 503B of the FD&C Act. Several changes affect peptides:
- GLP-1 shortages ended. FDA declared the tirzepatide shortage resolved (confirmed December 19, 2024) and the semaglutide shortage resolved on February 21, 2025. The grace periods for compounders then ended in 2025 (FDA).
- Proposed 503B exclusion. On April 30, 2026, FDA proposed excluding semaglutide, tirzepatide and liraglutide from the 503B bulks list, with comments open through June 29, 2026 (Pharmacy Times).
- Retatrutide can't be compounded. FDA says retatrutide "cannot be used in compounding under federal law" (FDA).
- Category 2 changes. FDA's Category 2 list (substances that may present significant safety risks) still includes GHRP-2, GHRP-6, ipamorelin acetate and kisspeptin-10. As of its April 22, 2026 update, BPC-157, TB-500, CJC-1295 and others appear in a table of nominations "withdrawn by the nominators." Withdrawal isn't approval.
- July 2026 advisory vote. FDA's Pharmacy Compounding Advisory Committee reviewed seven peptides on July 23-24, 2026. According to McDermott Will & Schulte, it voted to recommend adding six, including BPC-157, to the 503A bulks list. The vote is non-binding.
None of this makes online research-use peptides legal for human use. Compounding rules apply to licensed pharmacies filling prescriptions.
State notes
States add their own rules for clinics and prescribers. Per McDermott Will & Schulte:
- Ohio Board of Pharmacy (December 2025): said "research purposes only" medications are unlawful for prescriber clinics and med spas to possess.
- Alabama Board of Medical Examiners (May 26, 2026, notice): told physicians not to compound, administer or dispense "non-FDA approved or research grade peptide" to patients.
We haven't surveyed all 50 states. If you work in a clinic, check your own state's pharmacy and medical boards.
Athletes: WADA rules
Legal to sell and allowed in sport are different questions. The WADA Prohibited List, with the 2026 edition in force from January 1, 2026, bans many peptides at all times:
- S2 (peptide hormones, growth factors and mimetics): includes growth hormone-releasing factors such as CJC-1295, sermorelin and tesamorelin, and growth hormone-releasing peptides (GHRPs), per a BSCG summary of the 2026 list.
- S0 (non-approved substances): covers any drug not approved for human therapeutic use by any government. BPC-157 was named as an S0 example starting with the 2022 list.
Tested athletes should assume an unapproved research peptide is prohibited.
If you're evaluating a vendor anyway
Legal risk and product risk are linked. Vendors that publish dosing guides or health claims are the ones FDA cites. Before relying on any supplier, check the FDA warning letter database, match the COA to your exact lot and verify it with the lab (how to read a peptide COA). Our list of the best place to buy peptides online rates eight US vendors on those points and discloses each one's red flags. It isn't a statement that any product is legal for human use.
State rules differ from federal ones; see our peptide laws by state guide.
Sources are linked inline. This guide will be updated as FDA acts on the July 2026 compounding vote and the proposed 503B exclusion.